论文部分内容阅读
本文分析新药心喘齐灵治疗50例冠心病心绞痛的临床疗效,发现缓解心绞痛症状的总有效率为90％,心电图改善的总有效率为66％,证阴了动物实验中对心喘齐灵能降低心肌耗氧和增加冠脉流量的作用。经血流动力学测定,本药能减慢心率、改善心肌收缩功能、增加心脏指数和每分排血量,而且有降低血小板聚集作用。部分病例的肺功能测定,发现治疗后通气功能有改善,并具平喘作用。作者认为本药副作用轻微,为治疗冠心病心绞痛、尤其伴有慢性支气管炎,气喘病例的有效药物。
This article analyzes the clinical efficacy of the new drug Astragalus in treating 50 cases of angina pectoris and found that the total effective rate of relieving angina pectoris was 90% and the total effective rate of electrocardiogram improvement was 66% Can reduce myocardial oxygen consumption and increase the role of coronary flow. Determination of menstrual flow, the drug can slow down the heart rate, improve myocardial systolic function, increase cardiac index and each row of blood, and reduce platelet aggregation. In some cases of pulmonary function tests found that ventilation improved after treatment, and with asthma. The authors believe that the side effects of this medicine is mild, for the treatment of angina pectoris, especially with chronic bronchitis, asthma and effective drugs.